Uli Schmitz
Company: Gilead Sciences
Job title: Executive Director Structural Biology and Chemistry
Seminars:
Panel Discussion: Defining the Route Towards Investments for AI-Enabled Drug Discovery & Preclinical Development 4:00 pm
Delivering the promise of AI by proving AI discoveries can be translated into drugs or benefits What are the attributes that draw investors’ interests? Delving into start-up hurdles, VC funding and grants: how do you bring business acumen to big partnerships?Read more
day: Day Two
Chair’s Opening Remarks 8:25 am
day: Day One